XML 60 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
October 2022 PIPE Transaction
At The Market Sales Agreement
4SC Royalty Settlement
Common Stock
Common Stock
October 2022 PIPE Transaction
Common Stock
At The Market Sales Agreement
Common Stock
4SC Royalty Settlement
Additional Paid-in Capital
Additional Paid-in Capital
October 2022 PIPE Transaction
Additional Paid-in Capital
At The Market Sales Agreement
Additional Paid-in Capital
4SC Royalty Settlement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021         26,335,418                  
Beginning balance at Dec. 31, 2021 $ 127,115       $ 3       $ 324,237       $ (252) $ (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (120,407)                         (120,407)
Foreign exchange translation adjustment 3,287                       3,287  
Stock-based compensation 7,929               7,929          
Issuance of common stock (in shares)           8,696,552 4,204,113 852            
Issuance of common stock   $ 55,989 $ 39,584 $ 5   $ 1       $ 55,988 $ 39,584 $ 5    
Shares issued in connection with the Company's employee stock purchase plan (in shares)         70,351                  
Shares issued in connection with the Company's employee stock purchase plan $ 182               182          
Ending balance (in shares) at Dec. 31, 2022 39,307,286       39,307,286                  
Ending balance at Dec. 31, 2022 $ 113,684       $ 4       427,925       3,035 (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (93,612)                         (93,612)
Foreign exchange translation adjustment 724                       724  
Stock-based compensation 7,102               7,102          
Issuance of common stock (in shares)             657,012              
Issuance of common stock     $ 853               $ 853      
Shares issued from exercise of pre-funded warrants (in shares)         5,096,552                  
Shares issued from exercise of pre-funded warrants 51               51          
Shares issued in connection with the Company's employee stock purchase plan (in shares)         116,880                  
Shares issued in connection with the Company's employee stock purchase plan $ 129               129          
Ending balance (in shares) at Dec. 31, 2023 45,177,730       45,177,730                  
Ending balance at Dec. 31, 2023 $ 28,931       $ 4       $ 436,060       $ 3,759 $ (410,892)